Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline Eye Drops in Open Angle Glaucoma
NCT05710198Phase 3Recruiting
- Sponsor
- Omikron Italia
- Start
- Dec 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citicoline in open-angle glaucoma (OAG), sponsored by Omikron Italia. Started Dec 2023; status: recruiting.
02
Drugs
citicoline
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT05710198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05710198.